Detalles de la búsqueda
1.
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.
Ann Allergy Asthma Immunol
; 128(2): 169-177, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699967
2.
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
J Asthma
; 59(7): 1420-1432, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338132
3.
Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent.
Pulm Pharmacol Ther
; 51: 18-25, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29763659
4.
Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology.
Pulm Pharmacol Ther
; 49: 67-74, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567116
5.
Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects.
Pulm Pharmacol Ther
; 53: 33-38, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30218695
6.
24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.
Respir Res
; 18(1): 157, 2017 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28821260
7.
Interdependence of baseline correction method and covariance structure for crossover TQT studies.
J Biopharm Stat
; 23(1): 82-97, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23331223
8.
Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis.
ERJ Open Res
; 9(3)2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37143828
9.
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users.
J Clin Psychopharmacol
; 32(4): 492-502, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722508
10.
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Br J Clin Pharmacol
; 74(1): 116-24, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22243494
11.
Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects.
Biopharm Drug Dispos
; 32(9): 525-9, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22031172
12.
Estimating time to steady state using the effective rate of drug accumulation.
Pharm Stat
; 10(1): 27-33, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-20035533
13.
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
Clin Drug Investig
; 41(6): 579-590, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089147
14.
Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Investig
; 59(1): 135-144, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32917556
15.
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD.
Int J Chron Obstruct Pulmon Dis
; 15: 43-56, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32021143
16.
Pharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed-Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single-Dose, Crossover Study in Healthy Adults.
Clin Pharmacol Drug Dev
; 8(2): 223-233, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29901860
17.
An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease.
J Aerosol Med Pulm Drug Deliv
; 32(1): 40-46, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335559
18.
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
J Clin Pharmacol
; 48(5): 592-8, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18353996
19.
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers.
J Clin Pharmacol
; 48(4): 418-27, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18258750
20.
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers.
J Clin Pharmacol
; 48(6): 734-44, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18508950